AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Glibenclamide 5 Mg ;

10 registrations across 1 African market— 10 active

Markets with Glibenclamide 5 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
GLIBENCLAMIDE
Tablets
🇪🇬EgyptChemical Industries Development (CID)active
Gliben
Tablets
🇪🇬EgyptEl-Nasr for Pharmaceutical Chemicalsactive
Rivanil
Tablets
🇪🇬EgyptRIVA PHARMAactive
Gliben
Tablets
🇪🇬EgyptEl-Nasr for Pharmaceutical Chemicalsactive
Rivanil
Tablets
🇪🇬EgyptRIVA PHARMAactive
Diaben
Tablets
🇪🇬Egyptislamic company for pharmaceuticals,chemicals and medical appliances (pharco pharmaceuticalsactive
Daonil®
Tablets
🇪🇬EgyptSanofi Egyptactive
Diaben
Tablets
🇪🇬Egyptislamic company for pharmaceuticals,chemicals and medical appliances (pharco pharmaceuticalsactive
Daonil®
Tablets
🇪🇬EgyptSanofi Egyptactive
GLIBENCLAMIDE
Tablets
🇪🇬EgyptChemical Industries Development (CID)active

Glibenclamide 5 Mg ; in Africa — Regulatory Overview

Glibenclamide 5 Mg ; is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.